JACOBUS 10 110 Pill - white oval, 11mm
Generic Name: amifampridine
Pill with imprint JACOBUS 10 110 is White, Oval and has been identified as Ruzurgi 10 mg. It is supplied by Jacobus Pharmaceutical Company Inc.
Ruzurgi is used in the treatment of Lambert-Eaton Myasthenic Syndrome and belongs to the drug class cholinergic muscle stimulants. Ruzurgi 10 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for JACOBUS 10 110
Ruzurgi
- Generic Name
- amifampridine
- Imprint
- JACOBUS 10 110
- Strength
- 10 mg
- Color
- White
- Size
- 11.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Cholinergic muscle stimulants
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Jacobus Pharmaceutical Company Inc.
- National Drug Code (NDC)
- 49938-0110
See also:
Firdapse
Firdapse (amifampridine phosphate) is an oral, nonspecific, voltage-dependent, potassium (K+) ...
Bloxiverz
Bloxiverz is used for reversal of neuromuscular blockade, urinary retention
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Mestinon
Mestinon (pyridostigmine) is used to increase muscle strength in conditions such as myasthenia ...
Regonol
Regonol is used for dysautonomia, myasthenia gravis, nerve agent pretreatment, reversal of ...
Pyridostigmine
Pyridostigmine is used for dysautonomia, myasthenia gravis, nerve agent pretreatment, reversal of ...
Neostigmine
Neostigmine is used for myasthenia gravis, reversal of neuromuscular blockade, reversal of ...
Amifampridine
Amifampridine is used for lambert-eaton myasthenic syndrome
More about Ruzurgi (amifampridine)
- Check interactions
- Compare alternatives
- Reviews (2)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: cholinergic muscle stimulants
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.